13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q1 2018. See the latest, Q3 2026 →

Reported value

$1.81B

−8.8% on the quarter before

Positions

22

11 new, 19 sold out

Top 10

86.8%

of the value

Est. gain

+$148.3M

on stocks held all quarter

Est. return

+13.4%

on those stocks since Q4 2017

Filed

May 15, 2018

On SEC EDGAR ↗

Positions as of Mar 31, 2018, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2017. Striped tiles are options.

Alphabet15%Amazon14%Microsoft12%Salesforce11%Intel7.1%
Nektar Therapeutics7.0%
Alibaba6.7%Micron6.3%Workday4.0%
Jd Com Inc4.0%
Netflix3.1%
Stamps Com Inc1.8%
Adobe1.5%
Tal Ed Group1.4%
Ac Immune Sa1.4%
Qualcomm1.3%
0.8%
0.7%
0.5%
0.5%

Largest buys

Since Q4 2017, sized at quarter-end prices.

  1. Intel~$128.3MNew, 0.0% → 7.1% of the portfolio+2,462,600 shares
  2. Alibaba~$120.7MNew, 0.0% → 6.7% of the portfolio+657,400 shares
  3. Micron~$114.1MNew, 0.0% → 6.3% of the portfolio+2,187,500 shares
  4. Netflix~$56.0MNew, 0.0% → 3.1% of the portfolio+189,700 shares
  5. Jd Com Inc~$27.7MAdded, 2.3% → 4.0% of the portfolio+684,800 shares
  6. Adobe~$26.5MNew, 0.0% → 1.5% of the portfolio+122,500 shares
  7. Tal Ed Group~$25.3MNew, 0.0% → 1.4% of the portfolio+682,000 shares
  8. Qualcomm~$22.8MNew, 0.0% → 1.3% of the portfolio+411,000 shares
  9. Vipshop Hldgs Ltd~$9.5MNew, 0.0% → 0.5% of the portfolio+572,800 shares
  10. Sterling Bancorp Del~$9.1MNew, 0.0% → 0.5% of the portfolio+401,600 shares

Largest sells

Since Q4 2017, sized at quarter-end prices.

  1. Meta~$191.0MSold out, 9.6% → 0.0% of the portfolio−1,082,200 shares
  2. Microsoft~$72.8MCut, 13.9% → 12.3% of the portfolio−797,600 shares
  3. Nektar Therapeutics~$68.2MCut, 5.5% → 7.0% of the portfolio−641,700 shares
  4. Eog Res Inc~$56.6MSold out, 2.9% → 0.0% of the portfolio−524,700 shares
  5. Wells Fargo Co New~$51.6MSold out, 2.6% → 0.0% of the portfolio−850,000 shares
  6. Bank Amer Corp~$50.7MSold out, 2.6% → 0.0% of the portfolio−1,717,500 shares
  7. Devon Energy Corp New~$41.8MSold out, 2.1% → 0.0% of the portfolio−1,009,800 shares
  8. Apache Corp~$38.1MSold out, 1.9% → 0.0% of the portfolio−903,000 shares
  9. Biogen Inc~$34.9MSold out, 1.8% → 0.0% of the portfolio−109,400 shares
  10. PayPal~$34.2MSold out, 1.7% → 0.0% of the portfolio−465,100 shares

Holdings

As of Mar 31, 2018; changes in shares since Dec 31, 2017.

Positions, sorted by share of the portfolio
HoldingValue
AlphabetCAP STK CL A · shares +0.7% · price −1.5%14.9%$268.8M−$4.2M
AmazonCOM · shares +1.7% · price +23.8%13.7%$247.3M+$46.7M
MicrosoftCOM · shares −25% · price +6.7%12.3%$221.8M+$13.9M
SalesforceCOM · shares −0.5% · price +13.8%11.0%$198.3M+$24.0M
IntelCOM · shares New7.1%$128.3M—
Nektar TherapeuticsCOM · shares −35% · price +77.9%7.0%$126.7M+$55.5M
AlibabaSPONSORED ADS · shares New6.7%$120.7M—
MicronCOM · shares New6.3%$114.1M—
WorkdayCL A · shares −32% · price +24.9%4.0%$72.4M+$14.4M
Jd Com IncSPON ADR CL A · shares +62% · price −2.2%4.0%$72.2M−$1.0M
NetflixCOM · shares New3.1%$56.0M—
Stamps Com IncCOM NEW · shares −6.0% · price +6.9%1.8%$31.8M+$2.1M
AdobeCOM · shares New1.5%$26.5M—
Tal Ed GroupSPONSORED ADS · shares New1.4%$25.3M—
Ac Immune SaSHS · shares 0% · price −19.2%1.4%$24.7M−$5.9M
QualcommCOM · shares New1.3%$22.8M—
Ctrip Com Intl LtdAMERICAN DEP SHS · shares −58% · price +5.7%0.79%$14.3M+$770,836
Yandex N VSHS CLASS A · shares 0% · price +20.5%0.66%$12.0M+$2.0M
Vipshop Hldgs LtdSPONSORED ADR · shares New0.53%$9.5M—
Sterling Bancorp DelCOM · shares New0.50%$9.1M—
Intra Cellular Therapies IncCOM · shares New0.35%$6.3M—
Pagseguro Digital Ltd ComCL A · shares New0.07%$1.3M—
Total 22 positions100%$1.81B+$148.3M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2017 to Q1 2018: 11 stocks held throughout, up $148.3M (+13.4%).

  1. Nektar Therapeutics+$55.5M+78%
  2. Amazon+$46.7M+24%
  3. Salesforce+$24.0M+14%
  4. Workday+$14.4M+25%
  5. Microsoft+$13.9M+7%
  6. Jd Com Inc−$1.0M−2%
  7. Alphabet−$4.2M−2%
  8. Ac Immune Sa−$5.9M−19%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free